Delivery Order SPE2DB22D3401-SPE2DB24FT2LP
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, provides for the delivery of MEKINIST 2 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The $8,878.79 firm fixed price delivery order was issued under an indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $2,589.70 for the provision of MEKINIST 0.5 MG TABLET medical products. The award was made on June 6, 2024 by the Defense Logistics Agency (DLA), a defense agency, with a completion date of June 28, 2024. The contract is a Firm Fixed Price arrangement, with no set-aside designation. Amerisourcebergen, a large pharmaceutical distribution company, holds a significant Indefinite...
- This federal contract award, with ID SPE2DB22D3004|SPE2DB25FPK75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $9,670.51 firm fixed-price delivery order is for the supply of MEKINIST 2 MG TABLET medication. The contract has an ultimate completion date of February 28, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide MEKINIST 2 MG TABLET UU 30S, a pharmaceutical product, with a potential value of $8,878.79. The order has a completion date of March 18, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with the Defense Logistics Agency valued at up to $999,999,999.00 through December 31, 2025,...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The $18,371.32 fixed-price award is for the delivery of 4,566,462,969 units of the drug MEKINIST 2 MG Tablet with a completion date of December 10, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and the award is...
- This is a firm-fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MEKINIST 2 MG TABLET medical products, with an ultimate completion date of July 7, 2025 and a ceiling value of $46,804.35. The contract is not set-aside and was awarded on June 12, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $8,552.49 firm fixed-price delivery order is for the supply of the medication Mekinist 0.5 mg tablets. The contract has a completion date of February 14, 2025 and does not utilize any set-aside designations. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract worth $2,589.70 by the Defense Logistics Agency (DLA) to provide MEKINIST 0.5 MG TABLET UU 30S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver...
- This federal contract award, valued at $2,589.70, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order for the supply of MEKINIST 0.5 MG TABLET, a pharmaceutical product, with a completion date of July 17, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD)...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MEKINIST 2 MG TABLET UU 30S, a prescription medication. The award, valued at $17,757.60, has an ultimate completion date of August 28, 2024. It is a firm-fixed-price contract and does not have a set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB24FT2LPDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, through its Corporate Office division, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $8,878.79 delivery order is for the supply of MEKINIST 2 MG TABLET UU 30S, a pharmaceutical product. The delivery order is a firm fixed price contract with an ultimate completion date of April 22, 2024. Amerisourcebergen Drug Corp, a for-profit organization, holds an indefinite delivery contract (IDC) with DLA with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The award does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.9k | 4/1/24 |